tbuckley/cabot-search huggingface dataset:
ENTEROVIRUS IN RESPIRATORY DISEASE
Journal: JAMA (1962)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE EFFECTS OF SERUM TREATED WITH PARARABIN
Authors: Edgard Zunz, Charles Mohilevith
Journal: The Journal of Experimental Medicine (1917)

On page 227, Vol. XXV, No. 2, February 1, 1917, line 20, for 2 or 3 minutes read 20 to 30 minutes. On page 228, lines 28, 29, and 30 should read: It should also be mentioned, as has been shown by the experiments of Bordet and Zunz with guinea pigs, that it is better to employ homologous serum; that is, rabbit serum.
The Interferons and Their Inducers: Molecular and Therapeutic Considerations
Authors: Sidney E. Grossberg
Journal: New England Journal of Medicine (1972)

Properties of InterferonCells from several different classes of animals, including teleost fishes, have been shown to produce interferon.4,112 One interesting biologic property of interferon is its so-called "species specificity," a term that is probably a misnomer. Cross-reactivity between human and simian cells by heterologous interferons has been noted,113 and among a number of avian species there was considerable cross-reactivity within orders.114 It may therefore be more accurate to refer to family or order specificity. Nonetheless, it is true that, in general, interferon is most active in the cells of the same animal species that produce . . .
European Perspectives
Journal: Circulation (2006)

W ith a minimal prevalence of just 15 cases per million, pulmonary arterial hypertension is a rare condition, and, considering this fact, a great deal of attention is focused on it from a scientific point of view, according to Dr Nazzareno Galiè."There are many ongoing trials with new pharmacological compounds," he says, "and the interest among physicians is also quite high, as the symposia on the condition, organised within the main frame of institutional congresses, are always well attended."In addition, there are 2 sets of guidelines on pulmonary arterial hypertension -one from the European Society of Cardiology and the other from the American College of Chest Physicians.Dr Galiè believes that it is remarkable that such detailed diagnostic and treatment guidelines have been provided for a rare disease.European countries, such as the United Kingdom, Italy, Belgium, Spain, Germany, Austria, and France, already have a small number of centres specialising in pulmonary hypertension, and Dr Galiè believes that this is the correct approach."It is very important that there is not a proliferation of centres, because it is important for a centre to have a critical number of patients to gain experience and to provide the appropriate care," he explains."If a hospital has only a handful of patients, experience cannot be collected, and the organisation will not be efficient."He emphasises that pulmonary arterial hypertension is a very distinct condition and should not be confused with pulmonary hypertension presenting with diseases such as chronic heart failure or pulmonary parenchymal diseases.
"USE OF HOLLOW TUBE FOLLOWING SUBMUCOUS RESECTION OF NASAL SEPTUM"
Journal: JAMA (1921)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Treatment of asthma with beclomethasone aerosol.
Authors: R Heald
Journal: BMJ (1972)

early stage.Most partially obstructive lesions, such as a tumour or stricture, will show a few levels long before actual obstruction occurs.Secondly, if this had been done and the diagnosis thus made early, the patient could probably have been cured by simply dis- continuing his tablets.-Iam, etc.,
A New Anti-Inflammatory Therapy (Infliximab) for Complicated Sarcoidosis
Journal: Annals of Internal Medicine (2001)

Summaries for Patients3 July 2001A New Anti-Inflammatory Therapy (Infliximab) for Complicated SarcoidosisSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-1-200107030-00009 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Sarcoidosis is a disease of unknown cause that produces chronic inflammation in many different organs of the body. The disease can appear in several ways, but it most often damages the lungs. Tissue samples from patients with sarcoidosis show a typical appearance under a microscope. Although mild cases of the disease frequently get better without treatment, severe cases often require treatment with corticosteroid medications. Inflammation in sarcoidosis involves the accumulation of tiny collections of cells (known as noncaseating granulomas) throughout the affected tissue. One of the cell types ... Author, Article, and Disclosure InformationThe summary below is from the full report titled “Treatment of Complicated Sarcoidosis with Infliximab Anti–Tumor Necrosis Factor-α Therapy.” It is in the 3 July 2001 issue of Annals of Internal Medicine (volume 135, pages 27-31). The authors are AMF Yee and MB Pochapin.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. Previousarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoTreatment of Complicated Sarcoidosis with Infliximab Anti–Tumor Necrosis Factor-α Therapy Arthur M.F. Yee and Mark B. Pochapin Metrics Cited byInfliximab as a therapy for non-Crohn?s enterocutaneous fistulae 3 July 2001Volume 135, Issue 1 Page: I-20 Keywords Cells Corticosteroid therapy Diarrhea Granulomas Inflammation Lungs Macrophages Muscles Necrosis Sarcoidosis ePublished: 3 July 2001 Issue Published: 3 July 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130
Authors: M Narazaki, K Yasukawa, T Saito, Y Ohsugi, H Fukui, Y Koishihara, GD Yancopoulos, T Taga, T Kishimoto
Journal: Blood (1993)
PHYSICIANS AND THE HARRISON NARCOTIC LAW
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Potential Usefulness of Biological Markers in Risk Assessment
Authors: Frederica Perera
Journal: Environmental Health Perspectives (1987)

Substantial data have been generated during the last 5 years in experimental systems and human populations which shed light on the potential usefulness of biological markers in human cancer risk assessment. Following a brief review of overall progress to date in the biomonitoring of human populations, this paper turns to the growing body of data regarding carcinogen-DNA and protein adducts as illustrative markers of biologically effective dose of carcinogens. The data base illustrates considerable human inter-individual variation in binding and the presence of significant "background" levels of adducts--both of which support the absence of human population thresholds for exposure to carcinogens. The contribution of adduct data to our understanding of the shape of low dose-response curve and the reliability of inter-species extrapolation, as well as the relevance of adducts to cancer risk, are also discussed. Even though adducts can now be useful in hazard identification or qualitative risk assessment, more research is needed before they can serve as quantitative predictors of human cancer risk.
New uncertainties in prenatal screening for neural tube defect.
Journal: BMJ (1981)

news programmes.Such meetings would not be for the airing of complaints, but for the free and frank exploration of difficulties in the relationship, and would provide an opportunity for newsmen to question doctors outside the context of particular news stories.Other, larger, meetings to tackle specific issues might occasionally be useful, not least in enabling a wider circle of doctors and reporters to meet each other.We also endorse the suggestion in your article about the development of a code of good practice, and hope that such a code might grow out of the experience of regular meetings between the professions.
Studies of Celiac Sprue: III. The Effect of Repeated Wheat Instillation into the Proximal Ileum of Patients on a Gluten-Free Diet
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
<i>ERJ</i> September Podcast: Challenges and perspectives in obstructive sleep apnoea
Journal: European Respiratory Journal (2018)

As part of the September issue, the European Respiratory Journal presents the latest in its series of podcasts. Section Editor David Gozal interviews Walter McNicholas (St Vincent's University Hospital and University College Dublin, Ireland) about a report by an ad hoc working group of the Sleep Disordered Breathing Group of the European Respiratory Society and the European Sleep Research Society.
Surgery of the Hand
Journal: JAMA (1941)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PECULIARITIES OF THE SURGICAL DISEASES AND INJURIES OF THE NECK.
Authors: EDMOND SOUCHON
Journal: JAMA (1897)

<h3>SURGICAL DISEASES AND INJURIES OF THE PAROTID REGION.</h3> <i>Congenital absence</i>of the parotid and atrophy of the gland are very rare. However, occasionally subjects are seen with a deep hollow between the ramus of the jaw and the mastoid process, showing the partial atrophy at least of the gland. <i>Congenital hypertrophies</i>are not on record. Branchial fibrochondromata are sometimes found over this region.<i>Acquired atrophy</i>or destruction of the gland has been observed as the result of neuroses, injuries, congestions (mumps), inflammations and gangrene due to general fevers.<i>Acquired hypertrophies</i>are represented by the various kinds of swellings of the region.<i>Swellings</i>may be due to some forms of injuries or neuroses. <i>Injuries</i>of the parotid region are rare; they are grave, on account of cicatricial disfigurements and injuries to the facial nerve and to Steno's duct. Punctured superficial wounds are of no consequence, nor are the deeper wounds unless
Chained Smoker
Authors: D S Shimm
Journal: Annals of Internal Medicine (1998)

On Being a Doctor15 August 1998Chained SmokerDavid S. Shimm, MDDavid S. Shimm, MDUniversity of Arizona; Tucson, AZ 85724Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-129-4-199808150-00013 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail The man sat in the examination chair as the physician talked to him. He could feel the sunlight coming through the window, warming his face. If he looked toward the window, the sunlight dazzled him, and when he turned his face away, it still painted the periphery of his vision with a haze of red. To his right, he could see where pieces of plaster had fallen out of the walls and ceiling of the small examination room, leaving specks and blotches of white drywall showing through the dull, lime-green paint. Farther to his right, he could see the metal ... Author, Article, and Disclosure InformationAuthors: David S. Shimm, MDAffiliations: University of Arizona; Tucson, AZ 85724Corresponding Author: David S. Shimm, MD, Department of Radiation Oncology, Health Sciences Center, University of Arizona, 1501 North Campbell Avenue, Tucson, AZ 85724. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 15 August 1998Volume 129, Issue 4 Page: 331-332 Keywords Alcohols Anesthetics Biopsy Cancer treatment Malignant tumors Mouth Nausea Pain Tongue Vision ePublished: 15 August 2000 Issue Published: 15 August 1998 Copyright & PermissionsCopyright © 1998 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
The rational clinical examination. A primer on the precision and accuracy of the clinical examination
Authors: D. L. Sackett
Journal: JAMA (1992)

THIS background paper will introduce and explain the terms and concepts that are being employed in the series of overviews on the rational clinical examination that begins in this issue ofTHE Journal. It includes definitions and explanations of certain key concepts, clinical examples, guides for reading clinical journals about a diagnostic test, and a blank "working table" that you can use to apply the concepts on your own. Accordingly, you may want to clip all or part of this and keep it handy as you read the overviews in this and subsequent issues. See also pp 2645 and 2650. Later background papers in this series will discuss selected issues in the precision and accuracy of the clinical examination in greater detail, or extend them to more complex diagnostic situations (readers who are impatient for these extensions can read about them now<sup>1</sup>). Of course, the precision and accuracy of
Fundamentals of Disease: A Textbook of Pathology and Clinical Pathology for Nurses
Journal: JAMA (1953)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Journals JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Look, Ma! No Pneumococcus!
Authors: Carol Potera
Journal: Environmental Health Perspectives (1999)

Pneumococcal diseases, caused by the bacterium Streptococcus pneumoniae, include pneumonia and otitis media, which accounts for some 12 million doctor visits per year in the United States alone. Each year around the world, pneumococcus causes 1.2 million deaths due to pneumonia, 39% of which are in children under the age of five. In a three-year Phase III clinical trial involving 38,000 children, in which half of the infants received a new pneumococcal vaccine and half received a placebo vaccine, the new vaccine demonstrated an efficacy rate of 100% against bacterial meningitis and bacteremia, the two most deadly pneumococcal afflictions.
...and Finding New Therapy
Journal: JAMA (1995)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Encouraging trend on prescription drug information
Authors: C. Marwick
Journal: JAMA (1997)

THE declared goal of providing adequate prescription drug information to 75% of patients by the year 2000 and to 95% by the year 2006 would seem to be within reach, if a trend that recent Food and Drug Administration (FDA) surveys have shown continues. Since 1992, the agency has conducted a telephone survey every 2 years of about 1000 consumers asking them about the amount and type of written and oral information they receive about all drugs they are prescribed. In the FDA's first survey, done in 1992,24% of the respondents said they had been given written information about their prescription drugs. By 1994 that figure had risen to 54%. In the latest survey, done last year, 67% reported they had received more than brief written information about their prescription product. "This indicates that the response of American health care professionals to this thirst for knowledge is increasingly positive," said